Issue 9, 2020

Fenretinide binding to the lysosomal protein saposin D alters ceramide solubilization and hydrolysis

Abstract

Fenretinide is a synthetic retinoid pharmaceutical linked to ceramide build-up in vivo. Saposin D is an intralysosomal protein necessary for ceramide binding/degradation. We show, via electronic absorption spectroscopy, fluorescence spectroscopy, and ceramide hydrolysis assays, that fenretinide is bound by saposin D {Ka = (1.45 ± 0.49) × 105 M−1}, and affects ceramide solubilization/degradation.

Graphical abstract: Fenretinide binding to the lysosomal protein saposin D alters ceramide solubilization and hydrolysis

Supplementary files

Article information

Article type
Research Article
Submitted
30 May 2020
Accepted
26 Jun 2020
First published
14 Jul 2020

RSC Med. Chem., 2020,11, 1048-1052

Fenretinide binding to the lysosomal protein saposin D alters ceramide solubilization and hydrolysis

B. T. Milliken, L. Melegari, G. L. Smith, K. Grohn, A. J. Wolfe, K. Moody, F. Bou-Abdallah and R. P. Doyle, RSC Med. Chem., 2020, 11, 1048 DOI: 10.1039/D0MD00182A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements